{"data":{"billId":"117-hr-7640","congress":117,"type":"HR","number":"7640","title":"To amend the Orphan Drug Act to reauthorize a program of grants and contracts for the development of drugs for rare diseases and conditions (commonly referred to as \"orphan drugs\").","shortTitle":null,"originChamber":"House","introducedDate":"2022-05-03","updateDate":"2025-04-07T15:04:58Z","latestAction":{"actionDate":"2022-05-03","text":"Referred to the House Committee on Energy and Commerce."},"policyArea":"Health","sponsors":[{"bioguideId":"B001257","district":12,"firstName":"Gus","fullName":"Rep. Bilirakis, Gus M. [R-FL-12]","isByRequest":"N","lastName":"Bilirakis","middleName":"M.","party":"R","state":"FL","url":"https://api.congress.gov/v3/member/B001257?format=json"}],"cosponsorsCount":1,"committeesCount":1,"actionsCount":3,"textVersionsCount":1,"url":"https://civdotiq.org/bill/117-hr-7640"},"meta":{"apiVersion":"v1","timestamp":"2026-10-04T08:05:42.104Z","source":"congress.gov","license":"MIT","documentation":"https://civdotiq.org/docs/api"}}